By Dr Moxit Shah,Endocrinologist In Ahmedabad
With the arrival of Mounjaro, Ozempic, Wegovy, and multiple generic semaglutide brands in India, patients now have more treatment options than ever before for diabetes, obesity, and weight loss.
One of the most common questions I hear in my endocrinology clinic is:
“Which is cheaper: Mounjaro, Ozempic, or generic semaglutide?”
The answer depends on your goals, budget, diabetes status, and expected weight loss.
In this article, I compare the latest prices of Mounjaro, Ozempic, and generic semaglutide in India.
Quick Price Comparison (2026)
| Medication | Approx Weekly Cost | Approx Monthly Cost |
|---|---|---|
| Generic Semaglutide | ₹325–₹450 | ₹1,300–₹1,800 |
| Ozempic | ₹1,415+ | ₹5,660–₹8,500+ |
| Mounjaro | ₹3,281+ | ₹13,125–₹25,781+ |
Prices vary depending on dose strength and pharmacy availability. Recent generic semaglutide launches have significantly reduced treatment costs in India.
What Is Generic Semaglutide?
Generic semaglutide contains the same active molecule used in Ozempic and Wegovy.
Following patent expiry in India, several pharmaceutical companies launched lower-cost semaglutide products, making GLP-1 therapy accessible to a much larger population. Generic options can start at approximately ₹1,300 per month, making them the most affordable injectable weight-loss and diabetes medications currently available.
Advantages
- Lowest cost
- Effective for diabetes control
- Clinically proven weight loss
- Increasing availability
Limitations
- May require vial-based administration in some brands
- Less convenient than premium prefilled pen devices
What Is Ozempic?
Ozempic is Novo Nordisk’s branded semaglutide injection.
It is administered once weekly and has become one of the most widely recognized diabetes and weight-loss medications globally.
Following major price reductions in India during 2026, Ozempic starter doses now cost approximately ₹5,660 per month.
Advantages
- Branded product
- Convenient pen device
- Strong evidence for diabetes and cardiovascular protection
- Significant weight loss benefits
Limitations
- More expensive than generic semaglutide
- Weight loss is generally less than that seen with Mounjaro
What Is Mounjaro?
Mounjaro (Tirzepatide) is the newest generation injectable medication.
Unlike semaglutide, Mounjaro acts on both GIP and GLP-1 receptors, producing greater reductions in appetite, body weight, and blood sugar levels.
Current monthly costs generally start around ₹13,125 and can exceed ₹25,000 at higher maintenance doses.
Advantages
- Most powerful weight-loss medication currently available
- Excellent HbA1c reduction
- Strong appetite suppression
- Superior weight-loss outcomes compared with semaglutide
Limitations
- Highest cost
- Not affordable for every patient
Which Medication Produces More Weight Loss?
In general:
- Mounjaro (highest weight loss)
- Ozempic
- Generic Semaglutide
Remember that Ozempic and generic semaglutide contain the same molecule. The primary difference is branding, delivery device, and cost rather than efficacy. Mounjaro’s dual GIP/GLP-1 mechanism typically produces greater weight reduction.
Which Provides the Best Value for Money?
Best Budget Option
Generic Semaglutide
Ideal for:
- Patients with limited budgets
- Type 2 diabetes
- Moderate weight-loss goals
Best Balance of Cost and Convenience
Ozempic
Ideal for:
- Patients preferring branded therapy
- Those wanting a user-friendly pen device
- Individuals seeking established cardiovascular data
Best Results Regardless of Cost
Mounjaro
Ideal for:
- Significant obesity
- Severe insulin resistance
- Patients seeking maximum weight reduction
If you want to know about side effect –visit-https://endocrinologistinahmedabad.com/mounjaro-ozempic-side-effects-what-every-patient-should-know/
My Opinion as an Endocrinologist
There is no single “best” medication for everyone.
For many Indian patients, generic semaglutide represents an excellent balance between affordability and effectiveness.
For patients requiring substantial weight loss, Mounjaro often delivers the best clinical outcomes, although at a considerably higher cost.
Treatment selection should always consider:
- Body weight
- HbA1c
- Presence of diabetes
- Budget
- Side-effect profile
- Long-term treatment goals
Consult Dr. Moxit Shah
If you are considering Mounjaro, Ozempic, Wegovy, or generic semaglutide for diabetes or weight loss, a specialist consultation can help determine which option is most appropriate for your health goals and budget.
Personalized treatment plans often achieve better and more sustainable outcomes than medication alone.
contact us on-9979992797
